New option listings for September 18th include – Abivax SA American Depositary Shares (ABVX).
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABVX:
- Abivax price target raised to $101 from $71 at Morgan Stanley
- Abivax SA Reports Financial Results and Strategic Advances
- Promising Outlook for Abivax SA: Buy Rating Supported by Strong Clinical Results and Financial Position
- Abivax Reports Increased Losses but Secures Major Funding in H1 2025
- Abivax SA Sponsored ADR (ABVX) Q2 Earnings Cheat Sheet